337 related articles for article (PubMed ID: 18688283)
81. The class II phosphatidylinositol 3 kinase C2beta is required for the activation of the K+ channel KCa3.1 and CD4 T-cells.
Srivastava S; Di L; Zhdanova O; Li Z; Vardhana S; Wan Q; Yan Y; Varma R; Backer J; Wulff H; Dustin ML; Skolnik EY
Mol Biol Cell; 2009 Sep; 20(17):3783-91. PubMed ID: 19587117
[TBL] [Abstract][Full Text] [Related]
82. Gal-3 (Galectin-3) and K
She G; Hou MC; Zhang Y; Zhang Y; Wang Y; Wang HF; Lai BC; Zhao WB; Du XJ; Deng XL
Hypertension; 2020 Feb; 75(2):393-404. PubMed ID: 31838908
[TBL] [Abstract][Full Text] [Related]
83. New positive Ca2+-activated K+ channel gating modulators with selectivity for KCa3.1.
Coleman N; Brown BM; Oliván-Viguera A; Singh V; Olmstead MM; Valero MS; Köhler R; Wulff H
Mol Pharmacol; 2014 Sep; 86(3):342-57. PubMed ID: 24958817
[TBL] [Abstract][Full Text] [Related]
84. Evidence of Decreased Activity in Intermediate-Conductance Calcium-Activated Potassium Channels During Retinoic Acid-Induced Differentiation in Motor Neuron-Like NSC-34 Cells.
Chen PC; Ruan JS; Wu SN
Cell Physiol Biochem; 2018; 48(6):2374-2388. PubMed ID: 30114691
[TBL] [Abstract][Full Text] [Related]
85. Naphtho[1,2-d]thiazol-2-ylamine (SKA-31), a new activator of KCa2 and KCa3.1 potassium channels, potentiates the endothelium-derived hyperpolarizing factor response and lowers blood pressure.
Sankaranarayanan A; Raman G; Busch C; Schultz T; Zimin PI; Hoyer J; Köhler R; Wulff H
Mol Pharmacol; 2009 Feb; 75(2):281-95. PubMed ID: 18955585
[TBL] [Abstract][Full Text] [Related]
86. Blockage of K(Ca)3.1 and Kv1.3 channels of the B lymphocyte decreases the inflammatory monocyte chemotaxis.
Zhang S; Wang X; Ju C; Zhu L; Du Y; Gao C
Int Immunopharmacol; 2016 Feb; 31():266-71. PubMed ID: 26795234
[TBL] [Abstract][Full Text] [Related]
87. The potassium channel KCa3.1 constitutes a pharmacological target for astrogliosis associated with ischemia stroke.
Yi M; Wei T; Wang Y; Lu Q; Chen G; Gao X; Geller HM; Chen H; Yu Z
J Neuroinflammation; 2017 Oct; 14(1):203. PubMed ID: 29037241
[TBL] [Abstract][Full Text] [Related]
88. Selective blockade of the intermediate-conductance Ca2+-activated K+ channel suppresses proliferation of microvascular and macrovascular endothelial cells and angiogenesis in vivo.
Grgic I; Eichler I; Heinau P; Si H; Brakemeier S; Hoyer J; Köhler R
Arterioscler Thromb Vasc Biol; 2005 Apr; 25(4):704-9. PubMed ID: 15662023
[TBL] [Abstract][Full Text] [Related]
89. The potassium channel KCa3.1 promotes cell proliferation by activating SKP2 and metastasis through the EMT pathway in hepatocellular carcinoma.
Du Y; Song W; Chen J; Chen H; Xuan Z; Zhao L; Chen J; Jin C; Zhou M; Tuo B; Zhao Y; Zheng S; Song P
Int J Cancer; 2019 Jul; 145(2):503-516. PubMed ID: 30628729
[TBL] [Abstract][Full Text] [Related]
90. Regulation of cell proliferation by intermediate-conductance Ca2+-activated potassium and volume-sensitive chloride channels in mouse mesenchymal stem cells.
Tao R; Lau CP; Tse HF; Li GR
Am J Physiol Cell Physiol; 2008 Nov; 295(5):C1409-16. PubMed ID: 18815226
[TBL] [Abstract][Full Text] [Related]
91. Complementary roles of KCa3.1 channels and β1-integrin during alveolar epithelial repair.
Girault A; Chebli J; Privé A; Trinh NT; Maillé E; Grygorczyk R; Brochiero E
Respir Res; 2015 Sep; 16(1):100. PubMed ID: 26335442
[TBL] [Abstract][Full Text] [Related]
92. Modulators of small- and intermediate-conductance calcium-activated potassium channels and their therapeutic indications.
Wulff H; Kolski-Andreaco A; Sankaranarayanan A; Sabatier JM; Shakkottai V
Curr Med Chem; 2007; 14(13):1437-57. PubMed ID: 17584055
[TBL] [Abstract][Full Text] [Related]
93. Protein histidine phosphatase 1 negatively regulates CD4 T cells by inhibiting the K+ channel KCa3.1.
Srivastava S; Zhdanova O; Di L; Li Z; Albaqumi M; Wulff H; Skolnik EY
Proc Natl Acad Sci U S A; 2008 Sep; 105(38):14442-6. PubMed ID: 18796614
[TBL] [Abstract][Full Text] [Related]
94. Retroviral glycoprotein-mediated immune suppression via the potassium channel K
Laska MJ; Moeller JB; Graversen JH; Strøbæk D; Blomster L; Christophersen P; Bahrami S
Clin Immunol; 2022 Sep; 242():109081. PubMed ID: 35905828
[TBL] [Abstract][Full Text] [Related]
95. Design of a potent and selective inhibitor of the intermediate-conductance Ca2+-activated K+ channel, IKCa1: a potential immunosuppressant.
Wulff H; Miller MJ; Hansel W; Grissmer S; Cahalan MD; Chandy KG
Proc Natl Acad Sci U S A; 2000 Jul; 97(14):8151-6. PubMed ID: 10884437
[TBL] [Abstract][Full Text] [Related]
96. KCa3.1 Channels and Glioblastoma: In Vitro Studies.
Klumpp L; Sezgin EC; Skardelly M; Eckert F; Huber SM
Curr Neuropharmacol; 2018; 16(5):627-635. PubMed ID: 28786347
[TBL] [Abstract][Full Text] [Related]
97. Conditional KCa3.1-transgene induction in murine skin produces pruritic eczematous dermatitis with severe epidermal hyperplasia and hyperkeratosis.
Lozano-Gerona J; Oliván-Viguera A; Delgado-Wicke P; Singh V; Brown BM; Tapia-Casellas E; Pueyo E; Valero MS; Garcia-Otín ÁL; Giraldo P; Abarca-Lachen E; Surra JC; Osada J; Hamilton KL; Raychaudhuri SP; Marigil M; Juarranz Á; Wulff H; Miura H; Gilaberte Y; Köhler R
PLoS One; 2020; 15(3):e0222619. PubMed ID: 32150577
[TBL] [Abstract][Full Text] [Related]
98. The Blockage of KCa3.1 Channel Inhibited Proliferation, Migration and Promoted Apoptosis of Human Hepatocellular Carcinoma Cells.
Liu Y; Zhao L; Ma W; Cao X; Chen H; Feng D; Liang J; Yin K; Jiang X
J Cancer; 2015; 6(7):643-51. PubMed ID: 26078795
[TBL] [Abstract][Full Text] [Related]
99. Peptide Lv augments intermediate-conductance calcium-dependent potassium channels (KCa3.1) in endothelial cells to promote angiogenesis.
Pham DL; Niemi A; Ko ML; Ko GYP
PLoS One; 2022; 17(10):e0276744. PubMed ID: 36282858
[TBL] [Abstract][Full Text] [Related]
100. Kca3.1-Related Cellular Signalling Involved in Cancer Proliferation.
Calderón Artavia CG; Arvelo Álvarez FA
Cell Physiol Biochem; 2024 Mar; 58(2):107-127. PubMed ID: 38623063
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
